These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26601990)

  • 1. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.
    Gimeno-García AZ; Triñanes J; Quintero E; Salido E; Nicolás-Pérez D; Adrián-de-Ganzo Z; Alarcón-Fernández O; Abrante B; Romero R; Carrillo M; Ramos L; Alonso I; Ortega J; Jiménez A
    Gastroenterol Hepatol; 2016; 39(7):433-41. PubMed ID: 26601990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
    Staack A; Badendieck S; Schnorr D; Loening SA; Jung K
    BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Diagnostic and Prognostic Significance of Serum Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Colorectal Cancer.
    Ozemir IA; Aslan S; Eren T; Bayraktar B; Bilgic C; Isbilen B; Yalman H; Yigitbasi R; Alimoglu O;
    Chirurgia (Bucur); 2016; 111(5):414-421. PubMed ID: 27819647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of neurotensin as a novel biomarker in the endoscopic screening of high-risk population for developing colorectal neoplasia.
    Kontovounisios C; Qiu S; Rasheed S; Darzi A; Tekkis P
    Updates Surg; 2017 Sep; 69(3):397-402. PubMed ID: 28560510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
    Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
    Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
    Wilhelmsen M; Christensen IJ; Rasmussen L; Jørgensen LN; Madsen MR; Vilandt J; Hillig T; Klaerke M; Nielsen KT; Laurberg S; Brünner N; Gawel S; Yang X; Davis G; Heijboer A; Martens F; Nielsen HJ
    Int J Cancer; 2017 Mar; 140(6):1436-1446. PubMed ID: 27935033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.
    Groblewska M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
    Folia Histochem Cytobiol; 2010 Dec; 48(4):564-71. PubMed ID: 21478099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive cytogenetic biomarkers for colorectal neoplasia in medium risk patients.
    Ionescu EM; Nicolaie T; Ionescu MA; Becheanu G; Andrei F; Diculescu M; Ciocirlan M
    J Med Life; 2015; 8(3):398-403. PubMed ID: 26351547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory Analysis of Plasma Neurotensin as a Novel Biomarker for Early Detection of Colorectal Polyp and Cancer.
    Qiu S; Nikolaou S; Fiorentino F; Rasheed S; Darzi A; Cunningham D; Tekkis P; Kontovounisios C
    Horm Cancer; 2019 Jun; 10(2-3):128-135. PubMed ID: 31093954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas.
    Taguchi A; Rho JH; Yan Q; Zhang Y; Zhao Y; Xu H; Tripathi SC; Wang H; Brenner DE; Kucherlapati M; Kucherlapati R; Boutin AT; Wang YA; DePinho RA; Feng Z; Lampe PD; Hanash SM
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1112-9. PubMed ID: 26342024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of faecal
    Wong SH; Kwong TNY; Chow TC; Luk AKC; Dai RZW; Nakatsu G; Lam TYT; Zhang L; Wu JCY; Chan FKL; Ng SSM; Wong MCS; Ng SC; Wu WKK; Yu J; Sung JJY
    Gut; 2017 Aug; 66(8):1441-1448. PubMed ID: 27797940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.
    Jobin G; Rodriguez-Suarez R; Betito K
    Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnifying narrow-band imaging with acetic acid to diagnose early colorectal cancer.
    Goto N; Kusaka T; Tomita Y; Tanaka H; Itokawa Y; Koshikawa Y; Yamaguchi D; Nakai Y; Fujii S; Kokuryu H
    World J Gastroenterol; 2014 Nov; 20(43):16306-10. PubMed ID: 25473188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.
    Wilson S; Damery S; Stocken DD; Dowswell G; Holder R; Ward ST; Redman V; Wakelam MJ; James J; Hobbs FD; Ismail T
    Br J Cancer; 2012 Apr; 106(8):1431-8. PubMed ID: 22433968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.
    Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
    Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients.
    Hurst NG; Stocken DD; Wilson S; Keh C; Wakelam MJ; Ismail T
    Br J Cancer; 2007 Oct; 97(7):971-7. PubMed ID: 17912241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients.
    Tutton MG; George ML; Eccles SA; Burton S; Swift RI; Abulafi AM
    Int J Cancer; 2003 Nov; 107(4):541-50. PubMed ID: 14520690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with colorectal flat adenoma detection.
    Nicolás-Pérez D; Parra-Blanco A; Gimeno-García AZ; Ortega-Sánchez JA; Carrillo-Palau M; Jiménez-Sosa A; Quintero-Carrion E
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):302-8. PubMed ID: 23169312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.